Stockscreener 앱 받기
1.455
6.21%
0.0851
시장 영업 전:
1.46
0.005
+0.34%
전일 마감가:
$1.3699
열려 있는:
$1.34
하루 거래량:
201.77K
Relative Volume:
0.68
시가총액:
$7.97M
수익:
-
순이익/손실:
$-6.91M
주가수익비율:
-0.4463
EPS:
-3.26
순현금흐름:
$-6.14M
1주 성능:
+14.57%
1개월 성능:
+0.34%
6개월 성능:
-22.93%
1년 성능:
-56.82%
1일 변동 폭
$1.34
$1.47
1주일 범위
$1.24
$1.47
52주 변동 폭
$1.15
$23.80
Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile
GLMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GLMD
Galmed Pharmaceuticals Ltd
|
1.455 | 7.51M | 0 | -6.91M | -6.14M | -3.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.48 | 101.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
482.13 | 59.64B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.53 | 59.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
767.00 | 47.00B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
351.13 | 38.12B | 3.81B | -644.79M | -669.77M | -6.24 |
Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-05-22 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2020-02-04 | 개시 | Craig Hallum | Buy |
| 2020-01-30 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-12-02 | 개시 | Canaccord Genuity | Buy |
| 2018-12-12 | 개시 | B. Riley FBR | Buy |
| 2018-08-02 | 재확인 | Maxim Group | Buy |
| 2018-07-13 | 개시 | Stifel | Buy |
| 2018-07-12 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-06-12 | 재확인 | H.C. Wainwright | Buy |
| 2018-03-15 | 업그레이드 | Maxim Group | Hold → Buy |
| 2018-02-14 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2018-02-12 | 재확인 | H.C. Wainwright | Buy |
| 2017-11-15 | 개시 | ROTH Capital | Buy |
| 2017-08-08 | 재확인 | H.C. Wainwright | Buy |
| 2017-07-31 | 재확인 | Maxim Group | Buy |
| 2016-08-01 | 재확인 | Maxim Group | Buy |
| 2016-07-06 | 재개 | ROTH Capital | Buy |
| 2016-03-28 | 재개 | H.C. Wainwright | Buy |
| 2015-06-23 | 개시 | H.C. Wainwright | Buy |
| 2015-05-06 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Galmed Pharmaceuticals Ltd 주식(GLMD)의 최신 뉴스
What indicators show strength in Galmed Pharmaceuticals Ltd.Quarterly Risk Review & AI Based Buy and Sell Signals - Newser
Best data tools to analyze Galmed Pharmaceuticals Ltd. stockMarket Performance Report & Long-Term Capital Growth Strategies - Newser
Statistical indicators supporting Galmed Pharmaceuticals Ltd.’s strengthJuly 2025 Spike Watch & Community Consensus Trade Signals - Newser
Backtesting results for Galmed Pharmaceuticals Ltd. trading strategiesQuarterly Investment Review & Real-Time Buy Zone Alerts - Newser
Earnings visualization tools for Galmed Pharmaceuticals Ltd.Trade Entry Summary & Proven Capital Preservation Methods - Newser
Why Galmed Pharmaceuticals Ltd. is moving today2025 Market Trends & Verified Entry Point Signals - Newser
Is this a good reentry point in Galmed Pharmaceuticals Ltd.July 2025 Patterns & Community Supported Trade Ideas - Newser
How high can Galmed Pharmaceuticals Ltd. stock go2025 Price Action Summary & Momentum Based Trading Ideas - Newser
Will Galmed Pharmaceuticals Ltd. stock go up soon2025 Top Gainers & Reliable Volume Spike Alerts - Newser
How to build a custom watchlist for Galmed Pharmaceuticals Ltd.Portfolio Risk Report & Fast Exit and Entry Trade Guides - Newser
Does Galmed Pharmaceuticals Ltd. fit your quant trading modelJuly 2025 Institutional & Intraday High Probability Alerts - Newser
Is Galmed Pharmaceuticals Ltd. stock poised for growthPortfolio Performance Report & Pattern Based Trade Signal System - Newser
Market reaction to Galmed Pharmaceuticals Ltd.’s recent newsTrade Ideas & AI Enhanced Trading Signals - Newser
Momentum divergence signals in Galmed Pharmaceuticals Ltd. chart2025 Market Sentiment & Weekly Watchlist for Hot Stocks - Newser
Tools to assess Galmed Pharmaceuticals Ltd.’s risk profileMarket Sentiment Summary & Technical Entry and Exit Tips - Newser
Can a trend reversal in Galmed Pharmaceuticals Ltd. lead to recovery2025 Bull vs Bear & Daily Oversold Bounce Ideas - Newser
Signal strength of Galmed Pharmaceuticals Ltd. stock in tech scanners2025 Key Lessons & Weekly Top Gainers Alerts - Newser
Galmed Pharmaceuticals Unveils Digital Asset Strategy and Modifies SEDDS Agreement - MSN
Volume Surge May Signal Institutional Interest in Galmed Pharmaceuticals Ltd.Earnings Risk Summary & Weekly Top Performers Watchlists - beatles.ru
Galmed Pharmaceuticals Ltd. Recovery Likely Here’s What Data ShowsJuly 2025 Trends & Expert Curated Trade Setups - beatles.ru
Applying sector rotation models to Galmed Pharmaceuticals Ltd.Market Weekly Review & AI Powered Buy/Sell Recommendations - Newser
How to build a dashboard for Galmed Pharmaceuticals Ltd. stockTrade Ideas & Daily Oversold Bounce Ideas - Newser
How to read the order book for Galmed Pharmaceuticals Ltd.Quarterly Profit Review & Consistent Profit Trading Strategies - Newser
Ranking Galmed Pharmaceuticals Ltd. among high performing stocks via toolsMarket Performance Report & Weekly Sector Rotation Insights - Newser
Is Galmed Pharmaceuticals Ltd. stock ready for a breakout2025 Winners & Losers & Safe Entry Momentum Tips - Newser
Can Galmed Pharmaceuticals Ltd. ride the EV waveQuarterly Risk Review & Low Risk Entry Point Guides - 뉴스영
Tools to monitor Galmed Pharmaceuticals Ltd. recovery probabilityDividend Hike & AI Driven Stock Price Forecasts - Newser
Using data tools to time your Galmed Pharmaceuticals Ltd. exitEntry Point & AI Driven Stock Reports - Newser
Using portfolio simulators with Galmed Pharmaceuticals Ltd. included2025 Market Outlook & High Conviction Buy Zone Alerts - Newser
Analyzing Galmed Pharmaceuticals Ltd. with multi timeframe chartsPortfolio Return Summary & AI Powered Trade Plan Recommendations - Newser
Sentiment analysis tools applied to Galmed Pharmaceuticals Ltd.2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - Newser
What machine learning models say about Galmed Pharmaceuticals Ltd.July 2025 Highlights & Risk Managed Investment Strategies - Newser
Galmed Pharmaceuticals Ltd (GLMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.96%
1.11%
자본화:
|
볼륨(24시간):